1
|
Agha SS, Riglin L, Carbury R, Blakey R, Shakeshaft A, Thapar AK, Tilling K, Collishaw S, Stergiakouli E, Thapar A, Langley K. Young Adult ADHD Symptoms in the General Population and Neurocognitive Impairment. J Atten Disord 2024; 28:89-98. [PMID: 37864348 PMCID: PMC10676027 DOI: 10.1177/10870547231201870] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/22/2023]
Abstract
OBJECTIVE Neurocognitive impairments are associated with child and adult ADHD in clinical settings. However, it is unknown whether adult ADHD symptoms in the general population are associated with the same pattern of cognitive impairment. We examined this using a prospective, population-based cohort spanning birth to age 25 years. METHODS We examined associations between self-reported adult ADHD symptoms and cognitive task performance (attention and response inhibition) in adulthood and childhood. RESULTS Self-rated ADHD symptoms at age 25 were associated with poorer performance in age 25 cognitive tasks capturing ADHD-related functioning (attention B = -0.03, 95% CI [0.05, -0.01], p = .005; response inhibition B = -0.03, 95% CI [-0.05, -0.01], p = .002). CONCLUSIONS Neurocognitive impairments linked to adult ADHD symptoms in the general population, are similar to those found in people with childhood ADHD symptoms and are consistent with findings in adult ADHD clinical samples.
Collapse
Affiliation(s)
- Sharifah Shameem Agha
- Division of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, UK
- Cwm Taf Morgannwg University Health Board, Wales, UK
- Wolfson Centre for Young People’s Mental Health, Cardiff University, UK
| | - Lucy Riglin
- Division of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, UK
- Wolfson Centre for Young People’s Mental Health, Cardiff University, UK
| | - Rhian Carbury
- Division of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, UK
| | - Rachel Blakey
- MRC Integrative Epidemiology Unit, University of Bristol, UK
| | - Amy Shakeshaft
- Division of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, UK
- Wolfson Centre for Young People’s Mental Health, Cardiff University, UK
| | - Ajay K. Thapar
- Division of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, UK
- Wolfson Centre for Young People’s Mental Health, Cardiff University, UK
| | - Kate Tilling
- MRC Integrative Epidemiology Unit, University of Bristol, UK
| | - Stephan Collishaw
- Division of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, UK
- Wolfson Centre for Young People’s Mental Health, Cardiff University, UK
| | | | - Anita Thapar
- Division of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, UK
- Wolfson Centre for Young People’s Mental Health, Cardiff University, UK
| | - Kate Langley
- Division of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, UK
- School of Psychology, Cardiff University, UK
| |
Collapse
|
2
|
Rastikerdar N, Nejati V, Sammaknejad N, Fathabadi J. Developmental trajectory of hot and cold executive functions in children with and without attention deficit-hyperactivity disorder (ADHD). RESEARCH IN DEVELOPMENTAL DISABILITIES 2023; 137:104514. [PMID: 37105003 DOI: 10.1016/j.ridd.2023.104514] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/14/2022] [Revised: 01/25/2023] [Accepted: 04/16/2023] [Indexed: 05/10/2023]
Abstract
BACKGROUND Children with attention deficit hyperactivity disorder (ADHD) have a delayed development. Two main cognitive models of ADHD are executive (cold) and motivational (hot) models. In this study, we aimed to compare the development of hot and cold executive functions in children with and without ADHD. METHODS AND PROCEDURES Forty-six children with ADHD symptoms (56% boys) and forty-four typically developing controls (54% boys), in three age groups of 6-8, 8-10 and 10-12 years, were participated in the study. Go/No-Go Task (GNGT), One-Back Test (OBT) and Shifting Attention Test (SAT), Delay Discounting Test (DDT) and Balloon Analogue Risk Task (BART) were used for assessment. OUTCOMES AND RESULTS Children with ADHD showed lower performance in GNG, OBT, SAT, and BART, but intact performance in DDT. The tasks' performance was significantly different between three age groups in GNG and SAT, but similar in OBT and BART. The interaction effect was significant only for the BART measures. CONCLUSIONS AND IMPLICATIONS Children with ADHD compared to typically developing children, experience impaired hot and cold executive functions. The cognitive delay was found only in risky decision making as a hot executive function.
Collapse
Affiliation(s)
- Najmeh Rastikerdar
- Institute for Cognitive and Brain Sciences, Shahid Beheshti University, Tehran, Iran
| | - Vahid Nejati
- Department of Psychology, Shahid Beheshti University, Tehran, Iran.
| | - Negar Sammaknejad
- Institute for Cognitive and Brain Sciences, Shahid Beheshti University, Tehran, Iran
| | - Jalil Fathabadi
- Department of Educational and Developmental Psychology, Shahid Beheshti University, Tehran, Iran
| |
Collapse
|
3
|
Wong YS, Willoughby AR, Machado L. Reconceptualizing mind wandering from a switching perspective. PSYCHOLOGICAL RESEARCH 2023; 87:357-372. [PMID: 35348846 PMCID: PMC9928802 DOI: 10.1007/s00426-022-01676-w] [Citation(s) in RCA: 7] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2021] [Accepted: 03/10/2022] [Indexed: 10/18/2022]
Abstract
Mind wandering is a universal phenomenon in which our attention shifts away from the task at hand toward task-unrelated thoughts. Despite it inherently involving a shift in mental set, little is known about the role of cognitive flexibility in mind wandering. In this article we consider the potential of cognitive flexibility as a mechanism for mediating and/or regulating the occurrence of mind wandering. Our review begins with a brief introduction to the prominent theories of mind wandering-the executive failure hypothesis, the decoupling hypothesis, the process-occurrence framework, and the resource-control account of sustained attention. Then, after discussing their respective merits and weaknesses, we put forward a new perspective of mind wandering focused on cognitive flexibility, which provides an account more in line with the data to date, including why older populations experience a reduction in mind wandering. After summarizing initial evidence prompting this new perspective, drawn from several mind-wandering and task-switching studies, we recommend avenues for future research aimed at further understanding the importance of cognitive flexibility in mind wandering.
Collapse
Affiliation(s)
- Yi-Sheng Wong
- Department of Psychology and Brain Health Research Centre, University of Otago, William James Building, 275 Leith Walk, Dunedin, 9016, New Zealand.
- Brain Research New Zealand, Auckland, New Zealand.
- School of Psychology and Clinical Language Sciences, University of Reading Malaysia, Nusajaya, Malaysia.
| | - Adrian R Willoughby
- School of Psychology and Clinical Language Sciences, University of Reading Malaysia, Nusajaya, Malaysia
- Department of Psychology, Monash University Malaysia, Subang Jaya, Malaysia
| | - Liana Machado
- Department of Psychology and Brain Health Research Centre, University of Otago, William James Building, 275 Leith Walk, Dunedin, 9016, New Zealand
- Brain Research New Zealand, Auckland, New Zealand
| |
Collapse
|
4
|
León-Barriera R, Ortegon RS, Chaplin MM, Modesto-Lowe V. Treating ADHD and Comorbid Anxiety in Children: A Guide for Clinical Practice. Clin Pediatr (Phila) 2023; 62:39-46. [PMID: 35854648 DOI: 10.1177/00099228221111246] [Citation(s) in RCA: 5] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Attention-deficit hyperactivity disorder (ADHD) is frequently comorbid with anxiety disorders with rates as high as 25% to 50% in children and adolescents. Despite various treatment options for ADHD symptoms, limited research addresses treatment in the context of comorbidity. This article seeks to provide a review of the evidence regarding treatment of this comorbid population. Distinct emotional, cognitive, and behavioral symptoms have been observed in this population, suggesting a need for tailored treatment. Despite common concerns about anxiety exacerbation, stimulant medications demonstrate good tolerability and good response in addressing symptoms. Atomoxetine has also demonstrated some benefit and good tolerability for treating this comorbid population. Selective serotonin reuptake inhibitors can be used as adjunctive treatment for anxiety but require careful monitoring of side effects. Cognitive behavioral therapy (CBT) is an important treatment to improve anxiety symptoms in the absence of significant ADHD symptoms. Psychosocial interventions are also essential to improve outcomes.
Collapse
Affiliation(s)
| | - Richard S Ortegon
- Department of Psychiatry, University of Connecticut, Farmington, CT, USA
| | - Margaret M Chaplin
- Department of Psychiatry, University of Connecticut, Farmington, CT, USA.,Department of Psychiatry, Farrel Treatment Center, New Britain, CT, USA
| | - Vania Modesto-Lowe
- Department of Psychiatry, University of Connecticut, Farmington, CT, USA.,Connecticut Valley Hospital, Middletown, CT, USA
| |
Collapse
|
5
|
Kenton JA, Young JW. Preclinical Evaluation of Attention and Impulsivity Relevant to Determining ADHD Mechanisms and Treatments. Curr Top Behav Neurosci 2022; 57:291-320. [PMID: 35606639 DOI: 10.1007/7854_2022_340] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
People with Attention-Deficit Hyperactivity Disorder (ADHD) exhibit inattention, hyperactivity, and/or impulsivity. Symptoms of ADHD emerge in childhood and can continue throughout adulthood. Clinical assessments to diagnose ADHD can include administration of continuous performance tests (CPTs). CPTs provide an objective measure of inattention, requiring individuals to respond to targets (attention), and inhibit response to non-targets (impulsivity). When investigating the mechanisms of, and novel treatments for, ADHD it is important to measure such behavioral domains (attention and impulsivity). Some well-established preclinical tasks purport to assess attention in rodents but, unlike CPTs, do not require non-target inhibition, limiting their ADHD-relevance.Recently developed tasks recreate CPTs for rodents. The 5-Choice CPT (5C-CPT) contains non-target stimuli, enabling use of signal detection theory to evaluate performance, consistent with CPTs. The 5C-CPT has been adapted for use in humans, enabling direct cross-species comparisons of performance. A newer task, the rodent CPT (rCPT), is a touchscreen-based analog of CPTs, utilizing symbols instead of a simple stimulus array. Currently, the rCPT may be more akin to a go/no-go task, equally presenting targets/non-targets, although numerous variants exist - a strength. The 5C-CPT and rCPT emulate human CPTs and provide the most up-to-date information on ADHD-relevant studies for understanding attention/impulsivity.
Collapse
Affiliation(s)
- Johnny A Kenton
- Department of Psychiatry, University of California San Diego, La Jolla, CA, USA
| | - Jared W Young
- Department of Psychiatry, University of California San Diego, La Jolla, CA, USA.
- Research Service, VA San Diego Healthcare System, San Diego, CA, USA.
| |
Collapse
|
6
|
Roth Y, Tendler A, Arikan MK, Vidrine R, Kent D, Muir O, MacMillan C, Casuto L, Grammer G, Sauve W, Tolin K, Harvey S, Borst M, Rifkin R, Sheth M, Cornejo B, Rodriguez R, Shakir S, Porter T, Kim D, Peterson B, Swofford J, Roe B, Sinclair R, Harmelech T, Zangen A. Real-world efficacy of deep TMS for obsessive-compulsive disorder: Post-marketing data collected from twenty-two clinical sites. J Psychiatr Res 2021; 137:667-672. [PMID: 33183769 DOI: 10.1016/j.jpsychires.2020.11.009] [Citation(s) in RCA: 30] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/05/2020] [Revised: 10/26/2020] [Accepted: 11/01/2020] [Indexed: 10/23/2022]
Abstract
BACKGROUND Deep transcranial magnetic stimulation (dTMS) with the H7-coil was FDA cleared for obsessive-compulsive disorder (OCD) in August 2018 based on multicenter sham-controlled studies. Here we look at the efficacy of dTMS for OCD in real world practices. METHODS All dTMS clinics were asked to supply their data on treatment details and outcome measures. The primary outcome measure was response, defined by at least a 30% reduction in the Yale Brown Obsessive Compulsive Scale (YBOCS) score from baseline to endpoint. Secondary outcome measures included first response, defined as the first time the YBOCS score has met response criteria, and at least one-month sustained response. Analyses included response rate at the endpoint (after 29 dTMS sessions), number of sessions and days required to reach first response and sustained response. RESULTS Twenty-two clinical sites with H7-coils provided data on details of treatment and outcome (YBOCS) measures from a total of 219 patients. One-hundred-sixty-seven patients who had at least one post-baseline YBOCS measure were included in the main analyses. Overall first and sustained response rates were 72.6% and 52.4%, respectively. The response rate was 57.9% in patients who had YBOCS scores after 29 dTMS sessions. First response was achieved in average after 18.5 sessions (SD = 9.4) or 31.6 days (SD = 25.2). Onset of sustained one-month response was achieved in average after 20 sessions (SD = 9.8) or 32.1 days (SD = 20.5). Average YBOCS scores demonstrated continuous reduction with increasing numbers of dTMS sessions. CONCLUSIONS In real-world clinical practice, the majority of OCD patients benefitted from dTMS, and the onset of improvement usually occurs within 20 sessions. Extending the treatment course beyond 29 sessions results in continued reduction of OCD symptoms, raising the prospect of value for extended treatment protocols in non-responders.
Collapse
Affiliation(s)
- Yiftach Roth
- The Department of Life Sciences and the Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev, Beer-Sheva, Israel; BrainsWay Ltd, Israel.
| | - Aron Tendler
- The Department of Life Sciences and the Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev, Beer-Sheva, Israel; BrainsWay Ltd, Israel; Advanced Mental Health Care, 11903 Southern Blvd. Royal Palm Beach, FL 33411, USA
| | - Mehmet Kemal Arikan
- AKADEMIK Psychiatry& Psychotherapy Center Halaskargazi Cad. No: 103, Gün Apt, apartment: 4B 34371 Osmanbey - Istanbul, Turkey
| | - Ryan Vidrine
- TMS Health Solutions, 3300 WEBSTER STREET, SUITE #402 OAKLAND, CA, 94609, USA
| | - David Kent
- NuMe TMS, 2375 S Cobalt Point Way #102, Meridian, ID, 83642, USA
| | - Owen Muir
- Brooklyn Minds, 347 Grand St, Brooklyn, NY, 11211, USA
| | - Carlene MacMillan
- Brooklyn Minds, 10 W 37th Street, 5th Floor, New York, NY, 10018, USA
| | - Leah Casuto
- Lindner Center of Hope, 4075 Old Western Row Rd, Mason, OH, 45040, USA
| | - Geoffrey Grammer
- Greenbrook TMS, 8405 Greensboro Drive, Suite 120 McLean, VA 22102, USA
| | - William Sauve
- Greenbrook TMS, 8405 Greensboro Drive, Suite 120 McLean, VA 22102, USA
| | - Kellie Tolin
- Greenbrook TMS, 1500 Sunday Dr #200, Raleigh, NC, 27607, USA
| | - Steven Harvey
- Greenbrook TMS, 11477, Olde Cabin Rd, Suite 210 St. Louis MO 63141, USA
| | - Misty Borst
- Greenbrook TMS, 8850, Stanford Boulevard, Suite 3300Columbia, MD 21045, USA
| | - Robert Rifkin
- Greenbrook TMS, 11477, Olde Cabin Rd, Suite 210 St. Louis MO 63141, USA
| | - Manish Sheth
- Achieve TMS, 5060 Shoreham Place Suite 100 San Diego, CA, 92122, USA
| | - Brandon Cornejo
- Achieve TMS, 516 SE Morrison St. Suite #309 Portland, OR, 97214, USA
| | - Raul Rodriguez
- Delray Center for Healing, 403 SE 1st St, Delray Beach, FL, 33483, USA
| | - Saad Shakir
- Silicon Valley TMS, 2039 Forest Ave Esthetician Freshman Classroom, San Jose, CA, 95128, USA
| | - Taylor Porter
- Prime TMS, 1811 Wakarusa Dr #102, Lawrence, KS, 66047, USA
| | - Deborah Kim
- 3535 Market St, Philadelphia, PA, 19104, USA
| | - Brent Peterson
- The family Living Institute, 1307 Jamestown Rd STE 202, Williamsburg, VA 23185, USA
| | - Julia Swofford
- TMS NW, 5512 NE 109th Ct ste n, Vancouver, WA, 98662, USA
| | - Brendan Roe
- TMS NW, 5512 NE 109th Ct ste n, Vancouver, WA, 98662, USA
| | | | | | - Abraham Zangen
- The Department of Life Sciences and the Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev, Beer-Sheva, Israel
| |
Collapse
|
7
|
Soares LS, Alves ALC, Costa DDS, Malloy-Diniz LF, de Paula JJ, Romano-Silva MA, de Miranda DM. Common Venues in Romantic Relationships of Adults With Symptoms of Autism and Attention Deficit/Hyperactivity Disorder. Front Psychiatry 2021; 12:593150. [PMID: 34220561 PMCID: PMC8249738 DOI: 10.3389/fpsyt.2021.593150] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/24/2020] [Accepted: 05/21/2021] [Indexed: 11/13/2022] Open
Abstract
Introduction: Autism Spectrum Disorder (ASD) and Attention Deficit/Hyperactivity Disorder (ADHD) figures among the most common neurodevelopmental disorders. Despite having opposite stereotypes, both ADHD and ASD compromise, though in different ways, skills such as social interactions, communication skills, and social thinking, which may underlie difficulties in romantic relationships. Methods: We evaluated 306 adults about their romantic relationships and the intensity of their love. Participants were from one of four groups:, individuals with ASD-only traits, a group with symptoms of ADHD-only, participants with neither ADHD nor ASD symptoms (control) or from a fourth group of individuals with both ADHD and ASD traits. Results: The ASD traits group had fewer married people and more people who have never been married, while the rate of divorce was higher in the ADHD traits group. Regarding the intensity of love, the mean scores of the ADHD and the ADHD+ASD traits groups were higher in the Passionate Love Scale than the mean score of the control group. Passionate love in the ASD group was no different from the other groups. Small positive correlations were found between passionate love and ADHD and ASD behavioral problems. Conclusion: Marital status was distinct depending on symptoms of a neurodevelopmental disorder in adulthood. Also, ADHD and ASD symptoms were associated with greater passionate love. Therefore, ADHD and ASD behavioral dimensions may impact long-term and short-term experiences of a person's relationship with a significant other in distinct ways. Understanding how people with neurodevelopmental disorders experience love might help us to better clarify the mechanisms associated with their relationship patterns.
Collapse
Affiliation(s)
- Lorrayne Stephane Soares
- Programa de Pós-Graduação em Medicina Molecular, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
| | - Ana Luiza Costa Alves
- Programa de Pós-Graduação em Medicina Molecular, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
| | - Danielle de Souza Costa
- Programa de Pós-Graduação em Medicina Molecular, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
| | - Leandro Fernandes Malloy-Diniz
- Programa de Pós-Graduação em Medicina Molecular, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.,Department of Mental Health, Universidade Federal de Minas, Belo Horizonte, Brazil
| | - Jonas Jardim de Paula
- Programa de Pós-Graduação em Medicina Molecular, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.,Department of Psychology, Faculdade de Ciências Médicas de Minas Gerais, Belo Horizonte, Brazil
| | - Marco Aurélio Romano-Silva
- Programa de Pós-Graduação em Medicina Molecular, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.,Department of Mental Health, Universidade Federal de Minas, Belo Horizonte, Brazil
| | - Débora Marques de Miranda
- Programa de Pós-Graduação em Medicina Molecular, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.,Department of Pediatrics, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
| |
Collapse
|
8
|
Rüfenacht E, Euler S, Prada P, Nicastro R, Dieben K, Hasler R, Pham E, Perroud N, Weibel S. Emotion dysregulation in adults suffering from attention deficit hyperactivity disorder (ADHD), a comparison with borderline personality disorder (BPD). Borderline Personal Disord Emot Dysregul 2019; 6:11. [PMID: 31360522 PMCID: PMC6637623 DOI: 10.1186/s40479-019-0108-1] [Citation(s) in RCA: 20] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/26/2019] [Accepted: 06/25/2019] [Indexed: 12/20/2022] Open
Abstract
BACKGROUND Emotional dysregulation (ED) is now considered as an important symptom of attention deficit hyperactivity disorder (ADHD). It is believed to have a considerable impact on the severity of the disorder, one's global functioning, and the prognosis. Our research aimed to evaluate and compare ED and cognitive emotional regulation strategies between ADHD and borderline personality disorder (BPD) patients. METHODS Four hundred six French-speaking outpatients (N = 279 ADHD, N = 70 BPD, N = 60 BPD + ADHD) were assessed with the Emotion Reactivity Scale (ERS), the Cognitive Emotional Regulation Questionnaire (CERQ), The Basic Empathy Scale (BES-A), the Adult ADHD Self-Report Scale (ARSV-v1.1) and the Beck Depression Inventory II (BDI-II). ADHD, BPD and comorbid patients were compared with each other and with samples of controls extracted from already published data. RESULTS ADHD patients, although having higher ED than samples derived from the general population, had less ED, better control over their emotions with higher use of adaptive cognitive strategies and lesser use of non-adaptive strategies than BPD patients. However, ADHD subjects had similar scores as BPD subjects when looking at difficulties in perceiving self and others. ED generated considerable distress in all groups and was also positively associated with ADHD symptomatology. ADHD patients with comorbid BPD had the highest scores of ED. CONCLUSIONS Our results suggest that there may be similarly inefficient cognitive emotional regulation skills leading to ED in both disorders (ADHD and BPD). However, ADHD patients showed a higher use of adaptive cognitive emotional strategies and a lower level of ED than BPD patients.
Collapse
Affiliation(s)
- Eva Rüfenacht
- TRE Unit, Department of Psychiatry, Division of Psychiatric Specialties, Department of Mental Health and Psychiatry, University Hospitals of Geneva, 20bis rue de Lausanne, Geneva, Switzerland
| | - Sebastian Euler
- Department of Consultation Psychiatry and Psychosomatics, University Hospital Zurich and University of Zurich, Zurich, Switzerland
| | - Paco Prada
- TRE Unit, Department of Psychiatry, Division of Psychiatric Specialties, Department of Mental Health and Psychiatry, University Hospitals of Geneva, 20bis rue de Lausanne, Geneva, Switzerland
| | - Rosetta Nicastro
- TRE Unit, Department of Psychiatry, Division of Psychiatric Specialties, Department of Mental Health and Psychiatry, University Hospitals of Geneva, 20bis rue de Lausanne, Geneva, Switzerland
| | - Karen Dieben
- TRE Unit, Department of Psychiatry, Division of Psychiatric Specialties, Department of Mental Health and Psychiatry, University Hospitals of Geneva, 20bis rue de Lausanne, Geneva, Switzerland
| | - Roland Hasler
- TRE Unit, Department of Psychiatry, Division of Psychiatric Specialties, Department of Mental Health and Psychiatry, University Hospitals of Geneva, 20bis rue de Lausanne, Geneva, Switzerland
| | - Eléonore Pham
- TRE Unit, Department of Psychiatry, Division of Psychiatric Specialties, Department of Mental Health and Psychiatry, University Hospitals of Geneva, 20bis rue de Lausanne, Geneva, Switzerland
| | - Nader Perroud
- TRE Unit, Department of Psychiatry, Division of Psychiatric Specialties, Department of Mental Health and Psychiatry, University Hospitals of Geneva, 20bis rue de Lausanne, Geneva, Switzerland
- Department of Psychiatry, Faculty of Medicine, University of Geneva, Geneva, Switzerland
| | - Sébastien Weibel
- Pôle de Psychiatrie, Santé Mentale et Addictologie, University Hospital Strasbourg, Strasbourg, France
- INSERM 1114, Strasbourg, France
- FMTS, University of Strasbourg, Strasbourg, France
| |
Collapse
|